About the journal
Molecular Therapy: Oncology is an open-access journal published by Elsevier in United States, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 3,900 USD. Declared review time at DOAJ: 23 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 2950-3299
- Country
- United States
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,900 USD
- Articles in DOAJ
- 298
- Declared review time
- 23 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.sciencedirect.com/journal/molecular-therapy-oncology
Index listings
- DOAJ · 2024-09-20
- PUBMED · 2024-03-21
- Indexing
- DOAJ · PUBMED
- APC
- 3,900 USD
- Declared review time (DOAJ)
- 23 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
298
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
23weeks
Works in OpenAlex
463
Last recorded publication year
2026
h-index
14
i10-index
34
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2024-09-20
- Declared plagiarism screening
- Not declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 94%
- ORCID iDs in current deposits
- 87%
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Continues
- 2372-7705
- Source type
- journal
- NLM unique ID (PubMed)
- 9918752083706676
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- CAR-T cell therapy research
- CAR-T cell therapy research
- Virus-based gene therapy research
- Virus-based gene therapy research
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
Show all subjects (50)
- Cancer Research and Treatments
- Cancer Research and Treatments
- Viral Infectious Diseases and Gene Expression in Insects
- Cancer Immunotherapy and Biomarkers
- Viral Infectious Diseases and Gene Expression in Insects
- Cancer Immunotherapy and Biomarkers
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Glioma Diagnosis and Treatment
- RNA Interference and Gene Delivery
- RNA Interference and Gene Delivery
- CRISPR and Genetic Engineering
- CRISPR and Genetic Engineering
- Glioma Diagnosis and Treatment
- interferon and immune responses
- T-cell and B-cell Immunology
- interferon and immune responses
- T-cell and B-cell Immunology
- Neuroblastoma Research and Treatments
- Animal Virus Infections Studies
- Nanowire Synthesis and Applications
- Immune cells in cancer
- Neuroblastoma Research and Treatments
- Animal Virus Infections Studies
- Nanowire Synthesis and Applications
- Immune cells in cancer
- Cancer Mechanisms and Therapy
- Ubiquitin and proteasome pathways
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- Ubiquitin and proteasome pathways
- Cancer Mechanisms and Therapy
- Viral gastroenteritis research and epidemiology
- MicroRNA in disease regulation
- Cell death mechanisms and regulation
- PARP inhibition in cancer therapy
- Viral gastroenteritis research and epidemiology
- Cell death mechanisms and regulation
- PARP inhibition in cancer therapy
- MicroRNA in disease regulation
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
Keywords (DOAJ)
- cancer biology
- immunotherapy
- cancer
- oncology
- molecular therapy
- gene therapy
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ